Literature DB >> 27161030

Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.

Ravinea Manotheepan1, Tore K Danielsen2, Mani Sadredini2, Mark E Anderson3, Cathrine R Carlson2, Stephan E Lehnart4, Ivar Sjaastad2, Mathis K Stokke5.   

Abstract

AIMS: Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) is caused by mutations in the cardiac ryanodine receptor (RyR2) that lead to disrupted Ca(2+) handling in cardiomyocytes and ventricular tachycardia. The aim of this study was to test whether exercise training could reduce the propensity for arrhythmias in mice with the CPVT1-causative missense mutation Ryr2-R2474S by restoring normal Ca(2+) handling. METHODS AND
RESULTS: Ryr2-R2474S mice (RyR-RS) performed a 2 week interval treadmill exercise training protocol. Each exercise session comprised five 8 min intervals at 80-90% of the running speed at maximal oxygen uptake (VO2max) and 2 min active rest periods at 60%. VO2max increased by 10 ± 2% in exercise trained RyR-RS (ET), while no changes were found in sedentary controls (SED). RyR-RS ET showed fewer episodes of ventricular tachycardia compared with RyR-RS SED, coinciding with fewer Ca(2+) sparks and waves, less diastolic Ca(2+) leak from the sarcoplasmic reticulum, and lower phosphorylation levels at RyR2 sites associated with Ca(2) (+)-calmodulin-dependent kinase type II (CaMKII) compared with RyR-RS SED. The CaMKII inhibitor autocamtide-2-related inhibitory peptide and also the antioxidant N-acetyl-l-cysteine reduced Ca(2+) wave frequency in RyR-RS equally to exercise training. Protein analysis as well as functional data indicated a mechanism depending on reduced levels of oxidized CaMKII after exercise training. Two weeks of detraining reversed the beneficial effects of the interval treadmill exercise training protocol in RyR-RS ET.
CONCLUSION: Long-term effects of interval treadmill exercise training reduce ventricular tachycardia episodes in mice with a CPVT1-causative Ryr2 mutation through lower CaMKII-dependent phosphorylation of RyR2. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmias; CPVT1; Ca2+ homeostasis; CaMKII; Exercise training

Mesh:

Substances:

Year:  2016        PMID: 27161030      PMCID: PMC4957490          DOI: 10.1093/cvr/cvw095

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  26 in total

1.  Quantitative assessment of the SR Ca2+ leak-load relationship.

Authors:  Thomas R Shannon; Kenneth S Ginsburg; Donald M Bers
Journal:  Circ Res       Date:  2002-10-04       Impact factor: 17.367

Review 2.  Cellular basis of triggered arrhythmias in heart failure.

Authors:  Steven M Pogwizd; Donald M Bers
Journal:  Trends Cardiovasc Med       Date:  2004-02       Impact factor: 6.677

3.  Catecholaminergic polymorphic ventricular tachycardia: disease with different faces.

Authors:  Christian van der Werf; Arthur A M Wilde
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-06

Review 4.  Methods in cardiomyocyte isolation, culture, and gene transfer.

Authors:  William E Louch; Katherine A Sheehan; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2011-06-24       Impact factor: 5.000

5.  Aerobic exercise training improves skeletal muscle function and Ca2+ handling-related protein expression in sympathetic hyperactivity-induced heart failure.

Authors:  C R Bueno; J C B Ferreira; M G Pereira; A V N Bacurau; P C Brum
Journal:  J Appl Physiol (1985)       Date:  2010-07-01

6.  Echocardiographic criteria for detection of postinfarction congestive heart failure in rats.

Authors:  I Sjaastad; O M Sejersted; A Ilebekk; R Bjornerheim
Journal:  J Appl Physiol (1985)       Date:  2000-10

7.  Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes.

Authors:  Mathis K Stokke; Karina Hougen; Ivar Sjaastad; William E Louch; Sarah J Briston; Ulla H Enger; Kristin B Andersson; Geir Christensen; David A Eisner; Ole M Sejersted; Andrew W Trafford
Journal:  Cardiovasc Res       Date:  2009-12-17       Impact factor: 10.787

8.  Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice.

Authors:  Efrat Kurtzwald-Josefson; Edith Hochhauser; Guy Katz; Eyal Porat; Jonathan G Seidman; Christine E Seidman; Yelena Chepurko; Asher Shainberg; Michael Eldar; Michael Arad
Journal:  J Appl Physiol (1985)       Date:  2012-10-04

9.  Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1.

Authors:  Ravinea Manotheepan; Jørg Saberniak; Tore K Danielsen; Thor Edvardsen; Ivar Sjaastad; Kristina H Haugaa; Mathis K Stokke
Journal:  Am J Cardiol       Date:  2014-03-18       Impact factor: 2.778

10.  Chronic CaMKII inhibition blunts the cardiac contractile response to exercise training.

Authors:  Guri Kaurstad; Marcia N Alves; Ole J Kemi; Natale Rolim; Morten A Høydal; Helene Wisløff; Tomas O Stølen; Ulrik Wisløff
Journal:  Eur J Appl Physiol       Date:  2011-05-26       Impact factor: 3.078

View more
  4 in total

Review 1.  Inherited primary arrhythmia disorders: cardiac channelopathies and sports activity.

Authors:  S Marrakchi; I Kammoun; E Bennour; L Laroussi; M Ben Miled; S Kachboura
Journal:  Herz       Date:  2018-05-09       Impact factor: 1.443

2.  Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice.

Authors:  Hsiang-Ting Ho; Senthil Thambidorai; Björn C Knollmann; George E Billman; Sandor Györke; Anuradha Kalyanasundaram
Journal:  Heart Rhythm       Date:  2017-10-10       Impact factor: 6.343

3.  Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation.

Authors:  Tore K Danielsen; Ravinea Manotheepan; Mani Sadredini; Ida S Leren; Andrew G Edwards; Kevin P Vincent; Stephan E Lehnart; Ole M Sejersted; Ivar Sjaastad; Kristina H Haugaa; Mathis K Stokke
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

4.  The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1.

Authors:  Mani Sadredini; Ravinea Manotheepan; Stephan E Lehnart; Mark E Anderson; Ivar Sjaastad; Mathis K Stokke
Journal:  Physiol Rep       Date:  2021-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.